HUANG, SHENLIN,JIN, XIANMING,LIU, ZUOSHENG,POON, DANIEL,TELLEW, JOHN E.,WAN, YONGQIN,WANG, XING,XIE, YONGPING
申请号：
CA2771775
公开号：
CA2771775C
申请日:
2010.08.27
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The invention provides a novel class of compounds of formula 1, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
